Abstract Glycol free stable liquid compositions of Bendamustine The present invention relates to ready to use stable liquid pharmaceutical formulations of Bendamustine or a pharmaceutically acceptable salt thereof wherein the formulation is devoid of glycols. Further the present invention relates to pharmaceutical composition of Bendamustine hydrochloride comprising of saccharide, suitable solvent or mixture of solvents and suitable adjuvants thereof.